{"schema_version":"secwatch.filing_event.v1","accession":"0001718939-25-000043","form_type":"8-K","ticker":"IDAI","cik":"0001718939","company_name":"T Stamp Inc","filed_at":"2025-02-24T23:59:59+00:00","discovered_at":"2026-05-14T18:03:04.576921+00:00","generated_at":"2026-05-26T06:01:38.988349+00:00","sec_items":["8.01"],"event_type":"regulatory","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"T Stamp regains compliance with Nasdaq annual meeting requirement","bullets":["Received Nasdaq deficiency letter on Jan 21, 2025 for failing to hold annual meeting within 12 months of fiscal year end.","Held annual meeting on January 29, 2025 to address the deficiency.","Nasdaq notified T Stamp on February 21, 2025 that compliance with Listing Rule 5620(a) has been regained."],"urls":{"canonical":"https://secwatch.observer/filing/0001718939-25-000043","json":"https://secwatch.observer/filing/0001718939-25-000043.json","markdown":"https://secwatch.observer/filing/0001718939-25-000043.md","text":"https://secwatch.observer/filing/0001718939-25-000043.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1718939/000171893925000043/0001718939-25-000043-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1718939/000171893925000043/idai-20250221.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T06:01:38.988349+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"comparable_filings":[{"accession":"0001104659-26-067517","ticker":"CLIR","company_name":"ClearSign Technologies Corp","filed_at":"2026-05-28T20:19:02+00:00","headline":"ClearSign Technologies suspends ATM prospectus supplement for $10.39 million common stock offering; no shares sold","event_type":"regulatory","sec_items":["8.01","9.01"],"materiality_score":0.3,"calibrated_materiality_score":0.3,"match_reasons":["same SEC item: 8.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-067517","json":"https://secwatch.observer/filing/0001104659-26-067517.json","markdown":"https://secwatch.observer/filing/0001104659-26-067517.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1434524/000110465926067517/0001104659-26-067517-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1434524/000110465926067517/tm2615697d1_8k.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-234858","ticker":"QNCX","company_name":"Quince Therapeutics, Inc.","filed_at":"2026-05-21T21:06:52+00:00","headline":"Quince Therapeutics regains Nasdaq listing compliance via equity alternative","event_type":"regulatory","sec_items":["8.01"],"materiality_score":0.2,"calibrated_materiality_score":0.2,"match_reasons":["same SEC item: 8.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-234858","json":"https://secwatch.observer/filing/0001193125-26-234858.json","markdown":"https://secwatch.observer/filing/0001193125-26-234858.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1662774/000119312526234858/0001193125-26-234858-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1662774/000119312526234858/d139014d8k.htm"},"side_by_side_evidence":null},{"accession":"0001213900-26-056656","ticker":"AIRE","company_name":"reAlpha Tech Corp.","filed_at":"2026-05-14T20:20:34+00:00","headline":"reAlpha regains Nasdaq minimum bid price compliance; matter closed","event_type":"regulatory","sec_items":["8.01","9.01"],"materiality_score":0.3,"calibrated_materiality_score":0.3,"match_reasons":["same SEC item: 8.01","same event type: regulatory","similar materiality"],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-056656","json":"https://secwatch.observer/filing/0001213900-26-056656.json","markdown":"https://secwatch.observer/filing/0001213900-26-056656.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1859199/000121390026056656/0001213900-26-056656-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1859199/000121390026056656/ea0290935-8k_realpha.htm"},"side_by_side_evidence":null},{"accession":"0001140361-26-023698","ticker":"PDSB","company_name":"PDS Biotechnology Corp","filed_at":"2026-06-02T19:35:05+00:00","headline":"PDS Biotech regains Nasdaq minimum bid price compliance as of June 2, 2026","event_type":"regulatory","sec_items":["8.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same SEC item: 8.01","same event type: regulatory"],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-26-023698","json":"https://secwatch.observer/filing/0001140361-26-023698.json","markdown":"https://secwatch.observer/filing/0001140361-26-023698.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1472091/000114036126023698/0001140361-26-023698-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1472091/000114036126023698/ef20075449_8k.htm"},"side_by_side_evidence":null},{"accession":"0001493152-26-026760","ticker":"CING","company_name":"Cingulate Inc.","filed_at":"2026-06-02T12:10:25+00:00","headline":"Cingulate receives FDA Complete Response Letter for CTx-1301; no safety/efficacy issues, CMC-only","event_type":"regulatory","sec_items":["7.01","8.01","9.01"],"materiality_score":0.85,"calibrated_materiality_score":0.85,"match_reasons":["same SEC item: 8.01","same event type: regulatory"],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-26-026760","json":"https://secwatch.observer/filing/0001493152-26-026760.json","markdown":"https://secwatch.observer/filing/0001493152-26-026760.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1862150/000149315226026760/0001493152-26-026760-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1862150/000149315226026760/form8-k.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-252544","ticker":"MNKD","company_name":"MANNKIND CORP","filed_at":"2026-06-02T12:00:36+00:00","headline":"FDA approves Afrezza for pediatric diabetes patients ages 6+","event_type":"regulatory","sec_items":["8.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same SEC item: 8.01","same event type: regulatory"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-252544","json":"https://secwatch.observer/filing/0001193125-26-252544.json","markdown":"https://secwatch.observer/filing/0001193125-26-252544.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/899460/000119312526252544/0001193125-26-252544-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/899460/000119312526252544/mnkd-20260529.htm"},"side_by_side_evidence":null},{"accession":"0001193125-26-252475","ticker":"VERA","company_name":"Vera Therapeutics, Inc.","filed_at":"2026-06-02T11:05:16+00:00","headline":"Vera Therapeutics announces FDA alignment on earlier eGFR analysis for atacicept; results expected Q3 2026","event_type":"regulatory","sec_items":["8.01"],"materiality_score":0.75,"calibrated_materiality_score":0.75,"match_reasons":["same SEC item: 8.01","same event type: regulatory"],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-26-252475","json":"https://secwatch.observer/filing/0001193125-26-252475.json","markdown":"https://secwatch.observer/filing/0001193125-26-252475.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1831828/000119312526252475/0001193125-26-252475-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1831828/000119312526252475/vera-20260602.htm"},"side_by_side_evidence":null},{"accession":"0001108426-26-000030","ticker":"TXNM","company_name":"TXNM ENERGY INC","filed_at":"2026-06-01T21:54:12+00:00","headline":"TXNM subsidiaries: TNMP rate settlement with $20.5M storm rider, PNM resource plan with 1.65 GW renewables","event_type":"regulatory","sec_items":["7.01","8.01","9.01"],"materiality_score":0.65,"calibrated_materiality_score":0.65,"match_reasons":["same SEC item: 8.01","same event type: regulatory"],"urls":{"canonical":"https://secwatch.observer/filing/0001108426-26-000030","json":"https://secwatch.observer/filing/0001108426-26-000030.json","markdown":"https://secwatch.observer/filing/0001108426-26-000030.md","edgar_index":"https://www.sec.gov/Archives/edgar/data/1108426/000110842626000030/0001108426-26-000030-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/22767/000110842626000030/pnm-20260601.htm"},"side_by_side_evidence":null}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}